Monocyte recovery at day 100 is associated with improved survival in multiple myeloma patients who undergo allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2016 Feb;51(2):297-9
Date
10/13/2015Pubmed ID
26457907Pubmed Central ID
PMC4956087DOI
10.1038/bmt.2015.244Scopus ID
2-s2.0-84956915976 (requires institutional sign-in at Scopus site) 9 CitationsAuthor List
Dhakal B, Brazauskas R, Lara CA, Hari P, Pasquini M, D'Souza AAuthors
Ruta Brazauskas PhD Associate Professor in the Data Science Institute department at Medical College of WisconsinAnita D'Souza MD Professor in the Medicine department at Medical College of Wisconsin
Binod Dhakal MD Associate Professor in the Medicine department at Medical College of Wisconsin
Parameswaran Hari MD Adjunct Professor in the Medicine department at Medical College of Wisconsin
Marcelo C. Pasquini MD, MS Professor in the Medicine department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AdultAged
Allografts
Female
Follow-Up Studies
Hematopoietic Stem Cell Transplantation
Humans
Leukocyte Count
Male
Middle Aged
Monocytes
Multiple Myeloma
Recovery of Function
Retrospective Studies